Federal prosecutors secured six jury trial convictions in health-care fraud cases spanning five judicial districts between May 13 and June 1, 2026, with alleged losses topping $1.1 billion. The cases ranged from a billion-dollar telehealth billing operation in Fort Lauderdale to a Nashville nurse practitioner who distributed nearly one million opioid pills. Taken together, the three-week burst of guilty verdicts represents one of the most concentrated stretches of health-care fraud trial wins the Justice Department has announced in a single cycle, according to the national fraud enforcement division.
Why six convictions landed in under three weeks
The speed and geographic spread of these verdicts raise a pointed question: did the DOJ’s National Fraud Enforcement Division deliberately stack trial dates across Fort Lauderdale, Los Angeles, Detroit, New York, and Nashville to maximize enforcement impact? The compressed timeline suggests more than coincidence. Strike-force attorneys from the Healthcare Fraud Unit handled all six prosecutions, and the department’s own announcement groups them as a single enforcement result, indicating centralized case management. Comparing the five districts and six distinct fraud categories, the pattern is consistent with coordinated docket strategy rather than independent scheduling by local U.S. Attorney offices.
One concrete data point supports that reading. Ruby Scott, the owner of Delta Home Health Care LLC in Michigan, was initially charged as part of a nationwide enforcement action that charged 193 defendants with over $2.75 billion in false claims. Her conviction at trial fits a pipeline in which coordinated charging waves feed into clustered trial calendars months later. The same enforcement blueprint appears in the Fort Lauderdale telehealth case and in the Los Angeles Botox prosecution, both of which were developed by the Healthcare Fraud Unit and then brought to trial in rapid succession.
From billion-dollar telehealth schemes to Botox billing and opioid distribution
The largest case by dollar volume involved the owner of HealthSplash and DMERx, a health-care software platform that billed Medicare over $1 billion and collected more than $450 million in payments. Prosecutors described an industrial-scale operation that used foreign call centers, spam mailers, telemedicine orders, and kickbacks to generate fraudulent claims for unnecessary or never-provided items and services. An undercover agent who posed as a Medicare beneficiary helped build the trial record, which detailed how physicians were paid to sign off on pre-populated orders with little or no patient interaction.
Jurors in the Southern District of Florida heard evidence that the software platforms functioned as a hub for matching marketers, telehealth practitioners, and pharmacies in a closed loop of referrals. According to the Justice Department, the defendant used shell entities and layered transactions to obscure the flow of funds, while Medicare paid out hundreds of millions of dollars before the scheme was disrupted. The conviction capped a multi-year investigation that relied heavily on billing data analysis and cooperating witnesses inside the call-center network.
In Los Angeles, Dr. Violetta Mailyan was convicted of a $45 million Botox fraud scheme after DOJ data analytics flagged her billing as a statistical outlier. According to the department’s account of the California case, Mailyan submitted Medicare claims while on vacation overseas, billed for a beneficiary who was incarcerated, and filed claims on days her clinic was closed. Prosecutors argued that she routinely billed the highest-paying procedure codes for cosmetic Botox injections that were either never performed or were not covered by Medicare.
Court records show the case, CR 25-837(A)-HDV, was tried before Judge Hernan D. Vera in the Central District of California. Trial testimony from former employees described pre-signed treatment forms and instructions to maximize billing regardless of the actual services rendered. Medicare beneficiaries told jurors they received small cosmetic injections or no treatment at all, even as the clinic’s claims suggested extensive, medically necessary procedures. The jury’s guilty verdict underscored how claims data anomalies, once corroborated by witness accounts, can translate into compelling narratives of fraud at trial.
Ruby Scott’s conviction in Detroit centered on a $1.6 million Medicare fraud and kickback conspiracy tied to her company, Delta Home Health Care LLC. Prosecutors said Scott paid illegal kickbacks to patient recruiters and a hospital employee in exchange for referrals of Medicare beneficiaries who often did not qualify for home health services. Once enrolled, those patients generated a stream of claims for skilled nursing and therapy visits that were either not provided or were not medically necessary.
Evidence at trial included falsified patient assessments, boilerplate care plans, and documentation that appeared to have been copied across multiple files with only names and dates changed. Witnesses described how recruiters were paid per head and how some patients were coached to exaggerate symptoms to justify continued billing. The jury convicted Scott on fraud and kickback counts, reinforcing the Justice Department’s message that even comparatively smaller-dollar schemes will be pursued to verdict when they involve systematic abuse of vulnerable patients.
Rounding out the six convictions were cases in New York and Nashville involving durable medical equipment and opioid prescribing. In Tennessee, a nurse practitioner was found guilty of unlawfully distributing nearly one million opioid pills through high-volume prescriptions that prosecutors said bore little relation to legitimate pain management. Across the set of trials, the Justice Department emphasized the same themes: data-driven case selection, coordination across districts, and a willingness to take complex health-care fraud prosecutions to juries rather than relying solely on plea agreements.
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
